Multiple sclerosis patients and COVID-19

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Hubert Mado¹  Monika Adamczyk-Sowa¹ 

[1] Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland, 3 Maja Street 13/15, 41-800, Zabrze, Poland;

关键词: Multiple sclerosis;    MS;    COVID-19;    SARS-CoV-2;    DMT;   

DOI  :  10.1186/s41983-021-00287-3

来源: Springer

【 摘 要 】

Coronavirus disease 2019 (COVID-19) is now a major issue for all fields of medicine. Due to the higher mortality rate among patients with chronic diseases, it has also caused concern in patients with multiple sclerosis (MS), who in addition are often receiving immunosuppressive drugs. The aim of this article is to discuss what is currently known about the severity of COVID-19 in MS patients.

【 授权许可】

CC BY